Search Results - "proteomics"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Proteomics in cardiovascular disease clinical considerations /

    Published 2013
    Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
    Get full text
    Series
    Electronic Video
  2. 2

    Proteomics in kidney disease clinical considerations /

    Published 2013
    Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
    Get full text
    Series (Clinical proteomics)
    Series (Kidney in health and disease)
    Electronic Video
  3. 3

    Proteomics in cardiovascular disease clinical considerations /

    Published 2013
    Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
    Get full text
    Series
    Electronic Video
  4. 4

    Proteomics in kidney disease clinical considerations /

    Published 2013
    Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
    Get full text
    Series (Clinical proteomics)
    Series (Kidney in health and disease)
    Electronic Video
  5. 5

    Proteomics in cardiovascular disease clinical considerations /

    Published 2013
    Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
    Get full text
    Series
    Electronic Video
  6. 6

    Proteomics in kidney disease clinical considerations /

    Published 2013
    Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
    Get full text
    Series (Clinical proteomics)
    Series (Kidney in health and disease)
    Electronic Video
  7. 7

    Application of proteomics in fetal and neonatal medicine

    Published 2013
    Table of Contents: “…Contents: Application of proteomics in fetal and neonatal medicine -- Principles -- Samples -- Techniques -- Statistics -- Application to obstructive nephropathy in newborns -- Application in neonatal medicine -- Conclusion.…”
    Get full text
    Series
    Electronic Video
  8. 8

    Urinary proteomics in kidney and cardiovascular disease

    Published 2013
    Table of Contents: “…Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy.…”
    Get full text
    Series (Clinical proteomics)
    Series (Kidney in health and disease)
    Electronic Video
  9. 9

    Urinary proteomics in kidney and cardiovascular disease

    Published 2013
    Table of Contents: “…Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy.…”
    Get full text
    Series (Clinical proteomics)
    Series (Kidney in health and disease)
    Electronic Video
  10. 10

    Urinary proteomics in kidney and cardiovascular disease

    Published 2013
    Table of Contents: “…Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy.…”
    Get full text
    Series (Clinical proteomics)
    Series (Kidney in health and disease)
    Electronic Video
  11. 11

    Application of proteomics in fetal and neonatal medicine

    Published 2013
    Table of Contents: “…Contents: Application of proteomics in fetal and neonatal medicine -- Principles -- Samples -- Techniques -- Statistics -- Application to obstructive nephropathy in newborns -- Application in neonatal medicine -- Conclusion.…”
    Get full text
    Series
    Electronic Video
  12. 12

    Application of proteomics in fetal and neonatal medicine

    Published 2013
    Table of Contents: “…Contents: Application of proteomics in fetal and neonatal medicine -- Principles -- Samples -- Techniques -- Statistics -- Application to obstructive nephropathy in newborns -- Application in neonatal medicine -- Conclusion.…”
    Get full text
    Series
    Electronic Video
  13. 13

    The choroid in aging and disease

    Published 2016
    Table of Contents: “…Contents: Age-related Macular Degeneration (AMD) -- Drusen -- Atrophy -- Vascular changes -- Proteomics of choroidal thinning -- Fibrosis -- CD34 -- C-reactive protein accumulation -- Complement cascade: Membrane Attack Complex (MAC).…”
    Get full text
    Series
    Electronic Video
  14. 14

    The choroid in aging and disease

    Published 2016
    Table of Contents: “…Contents: Age-related Macular Degeneration (AMD) -- Drusen -- Atrophy -- Vascular changes -- Proteomics of choroidal thinning -- Fibrosis -- CD34 -- C-reactive protein accumulation -- Complement cascade: Membrane Attack Complex (MAC).…”
    Get full text
    Series
    Electronic Video
  15. 15

    The choroid in aging and disease

    Published 2016
    Table of Contents: “…Contents: Age-related Macular Degeneration (AMD) -- Drusen -- Atrophy -- Vascular changes -- Proteomics of choroidal thinning -- Fibrosis -- CD34 -- C-reactive protein accumulation -- Complement cascade: Membrane Attack Complex (MAC).…”
    Get full text
    Series
    Electronic Video
  16. 16
  17. 17

    Deciphering neurodegeneration models and methods /

    Published 2014
    Table of Contents: “…Contents: Deciphering Neurodegeneration: Models and Methods -- The challenge of neurodegeneration -- Huge diversity in cell types -- Nature versus nurture -- Reductionism versus systems biology -- Cellular models -- Yeast -- Primary cells -- Cell lines -- Stem cells -- Model organisms -- Caenorhabditis elegans -- Drosophila melanogaster -- Zebrafish -- Danio rerio -- Rodents -- Molecular biology approaches -- Knock out and knock in -- Genomic editing -- RNAi -- Overexpression -- Gene expression -- rtPCR -- Microarrays -- RNAseq -- Protein analysis -- Immunoblot -- ELISA -- Mass spec and proteomics -- Microscopy -- Immunocytochemistry -- Live cell imaging -- Electrophysiology.…”
    Get full text
    Series
    Electronic Video
  18. 18

    Deciphering neurodegeneration models and methods /

    Published 2014
    Table of Contents: “…Contents: Deciphering Neurodegeneration: Models and Methods -- The challenge of neurodegeneration -- Huge diversity in cell types -- Nature versus nurture -- Reductionism versus systems biology -- Cellular models -- Yeast -- Primary cells -- Cell lines -- Stem cells -- Model organisms -- Caenorhabditis elegans -- Drosophila melanogaster -- Zebrafish -- Danio rerio -- Rodents -- Molecular biology approaches -- Knock out and knock in -- Genomic editing -- RNAi -- Overexpression -- Gene expression -- rtPCR -- Microarrays -- RNAseq -- Protein analysis -- Immunoblot -- ELISA -- Mass spec and proteomics -- Microscopy -- Immunocytochemistry -- Live cell imaging -- Electrophysiology.…”
    Get full text
    Series
    Electronic Video
  19. 19

    Deciphering neurodegeneration models and methods /

    Published 2014
    Table of Contents: “…Contents: Deciphering Neurodegeneration: Models and Methods -- The challenge of neurodegeneration -- Huge diversity in cell types -- Nature versus nurture -- Reductionism versus systems biology -- Cellular models -- Yeast -- Primary cells -- Cell lines -- Stem cells -- Model organisms -- Caenorhabditis elegans -- Drosophila melanogaster -- Zebrafish -- Danio rerio -- Rodents -- Molecular biology approaches -- Knock out and knock in -- Genomic editing -- RNAi -- Overexpression -- Gene expression -- rtPCR -- Microarrays -- RNAseq -- Protein analysis -- Immunoblot -- ELISA -- Mass spec and proteomics -- Microscopy -- Immunocytochemistry -- Live cell imaging -- Electrophysiology.…”
    Get full text
    Series
    Electronic Video